Becker's Healthcare February 8, 2024
In a Feb. 5 meeting with retail pharmacy CEOs, HHS Secretary Xavier Becerra stressed that patients should not be paying the full list price or high copays for Pfizer’s Paxlovid drug.
While the distribution of Paxlovid has shifted to the commercial market and is no longer overseen by the federal government, HHS has negotiated pathways with Pfizer to ensure the drug is affordable and accessible at the pharmacy counter.
Through those pathways, people covered through Medicare and Medicaid are eligible to receive the COVID-19 antiviral for free through the end of the year....
Today's Sponsors
Today's Sponsor